BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
AstraZeneca
Merck
Daiichi Sankyo
Dow
Teva
Moodys
McKesson
Johnson and Johnson
Cipla

Generated: January 22, 2018

DrugPatentWatch Database Preview

Naltrexone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for naltrexone hydrochloride and what is the scope of naltrexone hydrochloride freedom to operate?

Naltrexone hydrochloride
is the generic ingredient in three branded drugs marketed by Accord Hlthcare, Apotex Inc, Barr, Elite Labs, Mallinckrodt, Sandoz, Sun Pharma Global, Teva Womens, and Pfizer Inc, and is included in nine NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for naltrexone hydrochloride. Fourteen suppliers are listed for this compound.
Pharmacology for naltrexone hydrochloride
Drug ClassOpioid Antagonist
Mechanism of ActionOpioid Antagonists

US Patents and Regulatory Information for naltrexone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Inc TROXYCA ER naltrexone hydrochloride; oxycodone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 207621-005 Aug 19, 2016 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer Inc TROXYCA ER naltrexone hydrochloride; oxycodone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 207621-004 Aug 19, 2016 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Pfizer Inc TROXYCA ER naltrexone hydrochloride; oxycodone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 207621-002 Aug 19, 2016 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer Inc TROXYCA ER naltrexone hydrochloride; oxycodone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 207621-003 Aug 19, 2016 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Womens REVIA naltrexone hydrochloride TABLET;ORAL 018932-001 Nov 20, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mallinckrodt NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 076264-001 Mar 22, 2002 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 074918-001 May 8, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer Inc TROXYCA ER naltrexone hydrochloride; oxycodone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 207621-006 Aug 19, 2016 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Pfizer Inc TROXYCA ER naltrexone hydrochloride; oxycodone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 207621-005 Aug 19, 2016 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Pfizer Inc TROXYCA ER naltrexone hydrochloride; oxycodone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 207621-002 Aug 19, 2016 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Harvard Business School
Argus Health
Farmers Insurance
US Army
Queensland Health
US Department of Justice
Chinese Patent Office
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot